Royalty Pharma plc (RPRX) Presents at Evercore 8th Annual Healthcare Conference Transcript [Seeking Alpha]
Royalty Pharma plc - Class A Ordinary Shares (RPRX)
US:NASDAQ Investor Relations:
ir.reprosrx.com/investor-relations
Company Research
Source: Seeking Alpha
Terrance Coyne - Executive VP & CFO Marshall Urist - Executive Vice President of Research & Investments Conference Call Participants Michael DiFiore - Evercore ISI Institutional Equities, Research Division Umer Raffat - Evercore ISI Institutional Equities, Research Division Presentation Michael DiFiore Evercore ISI Institutional Equities, Research Division [Audio Gap] Royalty Pharma plc; Terrance Coyne, CFO; Marshall Urist, EVP of Investments. Gentlemen, welcome. Thank you so much for making time to be with us at this conference. Before we get into Q&A, I would just love to hear your kind of state of the union of the business and what we could look forward to in the next 12 months. Terrance Coyne Executive VP & CFO Yes. So Thanks, Mike and Umer and Evercore for having us. I think 2025 has been a pretty amazing year for Royalty Pharma, a transformational year. We started the year off with a bang when we announced the major strategic transaction where we inter
Show less
Read more
Impact Snapshot
Event Time:
RPRX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
RPRX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
RPRX alerts
High impacting Royalty Pharma plc - Class A Ordinary Shares news events
Weekly update
A roundup of the hottest topics
RPRX
News
- Is Royalty Pharma (RPRX) Still Attractive After A 35% One Year Share Price Gain [Yahoo! Finance]Yahoo! Finance
- Royalty Pharma (NASDAQ:RPRX) was upgraded by analysts at UBS Group AG from a "neutral" rating to a "buy" rating.MarketBeat
- Teva Innovative Portfolio and Consistent Execution of Pivot to Growth Strategy Deliver Third Consecutive Year of Growth; Pipeline Positioned to Unlock Significant Value Potential [Yahoo! Finance]Yahoo! Finance
- Royalty Pharma (NASDAQ:RPRX) had its "buy" rating reaffirmed by analysts at Citigroup Inc..MarketBeat
- Jim Cramer on Royalty Pharma: “It's a Terrific Company” [Yahoo! Finance]Yahoo! Finance
RPRX
Sec Filings
- 2/4/26 - Form 4
- 2/3/26 - Form 144
- 2/2/26 - Form 144
- RPRX's page on the SEC website